Point72 Hong Kong LTD Athenex, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $4,075 - $8,202	-5,159 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $7,016 - $15,167	5,159 New	5,159 $7,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $1,632 - $2,257	-440 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $6,140 - $22,198	-1,505 Reduced 77.38%	440 $2,000
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $20,947 - $26,534	1,894 Added 3713.73%	1,945 $22,000
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $523 - $742	51 New	51 $1,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.